AZZ Inc. AZZ reported earnings per share of 88 cents for first-quarter fiscal 2022 (ended May 31, 2021), surpassing the Zacks Consensus Estimate of 62 cents by 41.9%. The bottom line also improved significantly from the year-ago quarter’s earnings of 21 cents by 319%.Total RevenuesIn the quarter under review, the company’s revenues came in at $229.8 million, outpacing the Zacks Consensus Estimate of $214 million by 7.4%.Driven by strength in its reportable segments, the top line increased 7.8% from $213.3 million in the prior-year quarter. Revenues from the Infrastructure Solutions and Metal Coatings segments rose 8.3% and 7.3% year over year, respectively.AZZ Inc. Price, Consensus and EPS Surprise AZZ Inc. price-consensus-eps-surprise-chart | AZZ Inc. QuoteQuarterly HighlightsTotal operating income in the quarter surged 114.5% to $30.7 million from the year-ago figure of $14.3 million.Selling, general and administrative expenses came in at $27.2 million, down 2.4% from $27.9 million in the prior-year quarter.Interest expenses fell 35.6% to $1.7 million from $2.6 million in the prior-year quarter.Bookings in first-quarter fiscal 2022 were up 31.4% year over year to $229.8 million.Financial HighlightsCash and cash equivalents as of May 31, 2021 amounted to $12.4 million compared with $26.4 million in the year-ago period.Long-term debt due after one year (net) was $185.4 million as of May 31, 2021 compared with $178.4 million on Feb 28, 2021.Net cash provided by operating activities at the end of first the three months of 2021 was $11.1 million while net cash used in operating activities was $11.2 million in the corresponding period of 2020.During the quarter, the company repurchased 125,770 shares worth $6.3 million.Capital expenditures amounted to $7.5 million in the quarter, down from $10.8 million in the prior-year period.GuidanceThe company lifted its fiscal 2022 earnings per share guidance to the $2.65-$3.05 range from the prior bandof $2.45-$2.95. The Zacks Consensus Estimate for the same is pegged at $2.69, which is near the lower end of the company’s expectation. It narrowed its revenue outlook to the range of $855-$935 million from the previous expectation of $835-$935 million.Zacks RankAZZ currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Other ReleasesEaton Corporation plc ETN reported first-quarter 2021 earnings of $1.44 per share, which surpassed the Zacks Consensus Estimate of $1.25 by 15.2%.Regal Beloit Corporation RBC delivered better-than-expected results for the first quarter of 2021 with earnings surpassing estimates by 17.86%.Emerson Electric Co’s EMR second-quarter fiscal 2021 (ended Mar 31, 2021) adjusted earnings of 97 cents per share beat the Zacks Consensus Estimate of 90 cents. Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Emerson Electric Co. (EMR): Free Stock Analysis Report Eaton Corporation, PLC (ETN): Free Stock Analysis Report Regal Beloit Corporation (RBC): Free Stock Analysis Report AZZ Inc. (AZZ): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research